Journal Mobile Options
Table of Contents
Vol. 32, No. 2, 2002
Issue release date: March–April 2002 (July 2002)
Section title: Original Paper
Pathophysiol Haemost Thromb 2002;32:92–96
(DOI:10.1159/000065082)

Platelets and Anticoagulant Capacity in Patients with Inflammatory Bowel Disease

Larsen T.B.a · Nielsen J.N.b · Fredholm L.b · Lund E.D.b · Brandslund I.b · Munkholm P.c · Hey H.d
aDepartment of Clinical Biochemistry, Section for Thrombosis and Hemostasis, Aalborg Hospital, Aalborg, bDepartment of Clinical Biochemistry, Vejle County Central Hospital, Vejle, cDepartment of Medical Gastroenterology, University Hospital of Copenhagen, Copenhagen, and dDepartment of Medical Gastroenterology, Vejle County Central Hospital, Vejle, Denmark
email Corresponding Author

Torben Bjerregaard Larsen, MD, PhD

Department of Clinical Biochemistry, Section for Thrombosis and Hemostasis

Aalborg Hospital, Hobrovej 18–22, PO Box 365

DK–9100 Aalborg (Denmark)

Tel. +45 9932 3180, Fax +45 9813 1196, E-Mail tblarsen@dadlnet.dk


References

  1. Grip O, Svensson PJ, Lindgren S: Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000;35:619–623.
  2. Lake AM, Stauffer JQ, Stuart MJ: Hemostatic alterations in inflammatory bowel disease: Response to therapy. Am J Dig Dis 1978;23:897–902.
    External Resources
  3. Edwards RL, Levine JB, Green R, Duffy M, Mathews E, Brande W, Rickles FR: Activation of blood coagulation in Crohn’s disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology 1987;92:329–337.
    External Resources
  4. Kjeldsen J, Lassen JF, Brandslund I, Schaffalitzky de Muckadell OB: Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease. Scand J Gastroenterol 1998;33:637–643.
  5. Hudson M, Hutton RA, Wakefield AJ, Sawyerr AM, Pounder RE: Evidence for activation of coagulation in Crohn’s disease. Blood Coagul Fibrinolysis 1992;3:773–778.
  6. Souto JC, Martinez E, Roca M, Mateo J, Pujol J, Gonzalez D, Fontcuberta J: Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995;40:1883–1889.
  7. Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, Van der Poll T: Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996;76:738–742.
  8. Heits F, Stahl M, Ludwig D, Stange EF, Jelkmann W: Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease. J Interferon Cytokine Res 1999;19:757–760.
  9. Rosendaal FR: Venous thrombosis: A multicausal disease. Lancet 1999;353:1167–1173.
  10. van Boven HH, Olds RJ, Thein SL, Reitsma PH, Lane DA, Briet E, Vandenbroucke JP, Rosendaal FR: Hereditary antithrombin deficiency. Heterogeneity of the molecular basis and mortality in Dutch families. Blood 1994;84:4209–4213.
  11. Esmon CT: The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989;264:4743–4746.
  12. Dahlbäck B: Protein S and C4b-binding protein: Components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991;66:49–61.
  13. Koutroubakis IE, Sfiridaki A, Mouzas IA, Maladaki A, Kapsoritakis A, Roussomoustakaki M, Kouroumakis EA, Manousos ON: Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol 2000;95:190–194.
  14. Santhosh-Kumar CR, Yohannan MD, Higgy KE, al Mashhadani SA: Thrombocytosis in adults. Analysis of 777 patients. J Intern Med 1991;229:493–495.
  15. Vila N, Reverter JC, Yague J, Chamorro A: Interaction between interleukin-6 and the natural anticoagulant system in acute stroke. J Interferon Cytokine Res 2000;20:325–329.
  16. Singleton JW: Clinical activity assessment in inflammatory bowel disease. Dig Dis Sci 1987;32:42S–45S.
  17. Salas A, Sans M, Soriano A, Reverter JC, Anderson DC, Pique JM, Panes J: Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut 2000;47:88–96.
  18. Collins CE, Rampton DS: Review article: Platelets in inflammatory bowel disease – pathogenetic role and therapeutic implications. Aliment Pharmacol Ther 1997;11:237–247.
  19. Carty E, MacEy M, Rampton DS: Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease. Aliment Pharmacol Ther 2000;14:1169–1179.
    External Resources